https://www.fluoridefreepeel.ca/response-to-peter-smith-canadian-anti-hate-network-re-virus-isolation/
On January 20, 2020, CDC received a clinical specimen collected from the first reported U.S. patient infected with SARS-CoV-2. CDC immediately placed the specimen into cell culture…”
Wait a minute. What was that again? They immediately placed the clinical specimen into cell culture. Huh?
Does this mean that the patient sample was immediately placed into a cell culture – a source of genetic contamination? Surely they mean that the virus was placed into a cell culture after it was isolated from the patient. Because if the patient sample was immediately contaminated with a cell culture, how could it then be established scientifically that the patient was infected with a new virus? I’m confused. Let’s keep reading.
“On February 2, 2020, CDC generated enough SARS-CoV-2 grown in cell culture to distribute to medical and scientific researchers.”
Fabulous, but how did they determine that a virus, and specifically SARS-COV-2, was even present? I’m still confused. Let’s keep reading.
“On February 4, 2020, CDC shipped SARS-CoV-2 to the BEI Resources Repository.”
Woah, talk about putting the cart before the horse. Let’s keep reading and figure this out.
“An article discussing the isolation and characterization of this virus specimen is available in Emerging Infectious Diseases.“
Ok, well we will definitely have to check out that article and get these details sorted out.
So the link for the article takes us to “Severe Acute Respiratory Syndrome Coronavirus 2 from Patient with Coronavirus Disease, United States” by Jennifer Harcourt (affiliation: CDC) et al.
Jennifer Harcourt… That is also the name of the first author listed in the study cited by Peter. They are the same study. Peter cited the preprint, and the CDC’s webpage links to the final published version. So let’s focus on the final version, which is published in the CDC’s own journal Emerging Infectious Diseases.